Brussels time
Horizon Europe is the EU’s key funding programme for research and innovation. Read more about the Horizon Europe programme here.
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of Horizon Europe destination 3 “Tackling diseases and reducing disease burden”.
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 3 “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim for delivering results that are directed, tailored towards and contributing to most of the following expected outcomes:
To be eligible for funding, applicants must be established in one of the following countries:
See the full list in the General Annexes.
The following exceptions apply:
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.
Unless otherwise provided for in the specific call conditions, only legal entities forming a consortium are eligible to participate in actions provided that the consortium includes, as beneficiaries, three legal entities independent from each other and each established in a different country as follows:
The total indicative budget for the topic is EUR 25.00 million.
The Commission estimates that an EU contribution of between EUR 6.00 and 7.00 million would allow these outcomes to be addressed appropriately.
Brussels time